Physician profile
Tera C Brooks
NPI 1245504380
$395.09
in general payments reported to CMS, 2019-2025
8 companies · $69.85 in 2025
The $69.85 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.03 · 2020: $19.76 · 2021: $65.08 · 2022: $81.46 · 2023: $37.50 · 2024: $100 · 2025: $69.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $196.60 | 2019-2025 | Proclaim, Freestyle Libre 2, Octrode |
| Novo Nordisk INC | $49.18 | 2024 | Rybelsus, Ozempic |
| Medtronic, INC. | $47.20 | 2022-2025 | Inceptiv |
| Merge Healthcare Incorporated | $28.88 | 2022 | |
| Dexcom, INC. | $21.18 | 2025 | Dexcom G6 Transmitter |
| Nevro Corp. | $17.97 | 2024 | Senza |
| Amgen INC. | $17.18 | 2025 | Otezla, Repatha |
| Agile Therapeutics, INC. | $16.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tera Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.